MCID: PRD007
MIFTS: 64

Periodontal Disease

Categories: Gastrointestinal diseases, Oral diseases

Aliases & Classifications for Periodontal Disease

MalaCards integrated aliases for Periodontal Disease:

Name: Periodontal Disease 12 76 15
Periodontal Diseases 55 44 73
Disease of Supporting Structures of Teeth 12
Periodontium Disorder 12
Gingival Diseases 73

Classifications:



External Ids:

Disease Ontology 12 DOID:3388
ICD10 33 K05.6 K08 K08.8
MeSH 44 D010510
NCIt 50 C63743
UMLS 73 C0031090

Summaries for Periodontal Disease

MalaCards based summary : Periodontal Disease, also known as periodontal diseases, is related to periodontosis and periodontitis, aggressive, 1, and has symptoms including halitosis, snoring and tenderness of gums. An important gene associated with Periodontal Disease is IL1B (Interleukin 1 Beta), and among its related pathways/superpathways are PEDF Induced Signaling and Innate Immune System. The drugs sodium fluoride and Triclosan have been mentioned in the context of this disorder. Affiliated tissues include bone, testes and kidney, and related phenotypes are homeostasis/metabolism and immune system

Wikipedia : 76 Periodontal disease, also known as gum disease, is a set of inflammatory conditions affecting the... more...

Related Diseases for Periodontal Disease

Diseases related to Periodontal Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 437)
# Related Disease Score Top Affiliating Genes
1 periodontosis 31.8 CD79A CXCL8 ELANE MMP9 TLR4 TNFSF11
2 periodontitis, aggressive, 1 31.7 CTSC IL1A MMP1 MMP8
3 apnea, obstructive sleep 31.0 CRP IL6 TNF
4 aggressive periodontitis 30.8 CTSC CXCL8 IL1A IL1B IL6 MMP8
5 arteries, anomalies of 30.7 CRP IL1B IL6 MMP9 TNF
6 aphthous stomatitis 30.7 IL1B IL6 TNF
7 gingivitis 30.7 CD79A CXCL8 ELANE GUSB IL1A IL1B
8 prostatitis 30.6 CXCL8 IL1B IL6 TNF
9 familial mediterranean fever 30.5 CRP IL1B TNF
10 chronic kidney failure 30.5 CD79A CRP IL6 TNFRSF11B
11 root resorption 30.5 IL1A IL1B TNFRSF11B TNFSF11
12 sleep apnea 30.5 CRP CXCL8 IL6 TNF
13 gingival overgrowth 30.4 IL1A MMP1 TIMP1
14 cytomegalovirus infection 30.4 CXCL8 IL6 TNF
15 peripheral artery disease 30.3 CRP IL6 TNFRSF11B
16 osteoporosis 30.3 CRP IL1A IL1B IL6 TNF TNFRSF11B
17 peptic ulcer disease 30.3 CXCL8 IL1B TNF
18 osteoporotic fracture 30.3 IL6 TNFRSF11B
19 pyoderma 30.3 CXCL8 MMP1 TNF
20 crohn's disease 30.3 CRP IL1B IL6 TLR4 TNF
21 duodenal ulcer 30.2 CXCL8 IL1B TNF
22 helicobacter pylori infection 30.2 CXCL8 IL1B TLR4 TNF
23 psoriasis 29.9 CXCL8 IL17A IL1A IL1B IL6 TNF
24 brucellosis 29.9 CRP CXCL8 IL6 TLR4 TNF
25 vascular disease 29.9 CRP IL6 MMP9 TNF TNFRSF11B
26 periodontitis, chronic 29.8 IL1B IL6 MMP1 MMP8 TLR2 TNFRSF11B
27 bacterial vaginosis 29.8 CXCL8 IL1A IL1B IL6 TLR2 TLR4
28 peritonitis 29.6 CRP CXCL8 IL1B IL6 TLR2 TNF
29 pulmonary emphysema 29.5 ELANE MMP1 MMP8 MMP9 TIMP1
30 arthritis 29.5 CXCL8 IL17A IL1A IL1B IL6 MMP1
31 meningitis 29.1 CRP CXCL8 IL1B IL6 MMP9 TLR2
32 myocardial infarction 28.9 CRP IL1B IL6 MMP2 MMP9 TIMP1
33 psoriatic arthritis 28.7 CRP IL17A IL1A IL1B IL6 MMP1
34 pulmonary disease, chronic obstructive 28.0 CRP CXCL8 ELANE IL17A IL6 MMP1
35 inflammatory bowel disease 27.6 CRP CXCL8 ELANE IL17A IL1A IL1B
36 periodontitis 27.5 CRP CTSC CXCL8 IL17A IL1A IL1B
37 rheumatoid arthritis 26.9 CD79A CRP CXCL8 IL17A IL1A IL1B
38 asthma 26.6 CD79A CXCL8 ELANE IL17A IL1A IL1B
39 ehlers-danlos syndrome, periodontal type, 1 11.1
40 irritant dermatitis 11.1 IL1A IL1B TNF
41 scorpion envenomation 11.0 IL6 TNF
42 laryngitis 11.0 IL1B IL6 TNF
43 acute vascular insufficiency of intestine 11.0 IL1B IL6 TNF
44 poems syndrome 11.0 IL1B IL6 TNF
45 uremic pruritus 11.0 CRP IL1B IL6
46 cysticercosis 11.0 IL1B IL6 TLR4
47 eales disease 11.0 IL1B IL6 TNF
48 post-transplant lymphoproliferative disease 11.0 IL1A IL6 TNF
49 endometritis 11.0 IL1B IL6 TNF
50 lacrimal apparatus disease 11.0 IL1B IL6 TNF

Graphical network of the top 20 diseases related to Periodontal Disease:



Diseases related to Periodontal Disease

Symptoms & Phenotypes for Periodontal Disease

UMLS symptoms related to Periodontal Disease:


halitosis, snoring, tenderness of gums, oral manifestations

MGI Mouse Phenotypes related to Periodontal Disease:

46 (show all 13)
# Description MGI Source Accession Score Top Affiliating Genes
1 homeostasis/metabolism MP:0005376 10.41 TIMP1 MMP1 MMP2 TLR2 MMP8 MMP9
2 immune system MP:0005387 10.39 TIMP1 MMP1 MMP2 TLR2 MMP8 MMP9
3 hematopoietic system MP:0005397 10.38 TIMP1 MMP2 TLR2 MMP9 TNFSF11 TNF
4 growth/size/body region MP:0005378 10.31 TIMP1 MMP2 TLR2 MMP9 IL6 TLR4
5 cardiovascular system MP:0005385 10.26 TIMP1 MMP2 TLR2 MMP9 IL6 TLR4
6 mortality/aging MP:0010768 10.13 MMP9 IL6 TIMP1 MMP2 TLR2 TLR4
7 integument MP:0010771 10.1 TLR2 MMP9 IL6 TNFSF11 TNF TLR4
8 neoplasm MP:0002006 10.1 TIMP1 MMP1 MMP2 TLR2 MMP8 MMP9
9 craniofacial MP:0005382 10.05 MMP2 TNFSF11 TNF TNFRSF11B IL17A IL1B
10 limbs/digits/tail MP:0005371 9.91 TIMP1 MMP9 TLR4 TNFSF11 TNF TNFRSF11B
11 renal/urinary system MP:0005367 9.7 MMP9 IL6 TLR2 TLR4 IL17A GUSB
12 respiratory system MP:0005388 9.61 TIMP1 MMP2 TLR2 MMP9 IL6 TLR4
13 skeleton MP:0005390 9.4 TIMP1 MMP2 TLR2 MMP9 IL6 TNFSF11

Drugs & Therapeutics for Periodontal Disease

Drugs for Periodontal Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 442)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1 sodium fluoride Approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 7681-49-4
2
Triclosan Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 3380-34-5 5564
3
Metronidazole Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 443-48-1 4173
4
Doxycycline Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 564-25-0 54671203
5
Levonorgestrel Approved, Investigational Phase 4 797-63-7, 17489-40-6 13109
6
Chlorhexidine Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 55-56-1 9552079 2713
7
Hyaluronic acid Approved, Vet_approved Phase 4,Phase 1,Phase 2,Not Applicable 9004-61-9 53477741
8
Amoxicillin Approved, Vet_approved Phase 4,Phase 2,Phase 3,Not Applicable 26787-78-0 33613
9
Epinephrine Approved, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1 51-43-4 5816
10
Racepinephrine Approved Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1 329-65-7 838
11
Hexetidine Approved, Investigational Phase 4 141-94-6
12
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 2,Not Applicable 22916-47-8 4189
13
Estradiol Approved, Investigational, Vet_approved Phase 4 50-28-2 5757
14 Estradiol valerate Approved, Investigational, Vet_approved Phase 4 979-32-8
15
Ethinyl Estradiol Approved Phase 4 57-63-6 5991
16
Moxifloxacin Approved, Investigational Phase 4 354812-41-2, 151096-09-2 152946
17
Norgestimate Approved, Investigational Phase 4 35189-28-7 6540478
18
Polyestradiol phosphate Approved Phase 4 28014-46-2
19
Menthol Approved Phase 4,Phase 3,Not Applicable,Early Phase 1 2216-51-5 16666
20
Zinc Approved, Investigational Phase 4,Phase 2,Phase 3,Not Applicable 7440-66-6 23994
21
Azithromycin Approved Phase 4,Phase 2,Not Applicable 83905-01-5 55185 447043
22
Metformin Approved Phase 4,Phase 2,Phase 3 657-24-9 14219 4091
23
Ciprofloxacin Approved, Investigational Phase 4,Phase 1,Not Applicable 85721-33-1 2764
24
Ethanol Approved Phase 4,Phase 3,Phase 2,Not Applicable 64-17-5 702
25
Acetaminophen Approved Phase 4,Phase 2,Phase 3,Not Applicable 103-90-2 1983
26
Lidocaine Approved, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1 137-58-6 3676
27
Prilocaine Approved Phase 4 721-50-6 4906
28
Alginic acid Approved, Investigational Phase 4 9005-32-7
29
Minocycline Approved, Investigational Phase 4,Phase 3,Phase 1,Not Applicable 10118-90-8 5281021
30
Albendazole Approved, Vet_approved Phase 4 54965-21-8 2082
31
Methyl salicylate Approved, Vet_approved Phase 4,Not Applicable 119-36-8 4133
32
Thymol Approved Phase 4,Not Applicable 89-83-8 6989
33
Alendronate Approved Phase 4,Phase 2,Phase 3 121268-17-5, 66376-36-1 2088
34
Edetic Acid Approved, Vet_approved Phase 4,Not Applicable 60-00-4, 62-33-9 6049
35
Pentetic acid Approved Phase 4,Not Applicable 67-43-6
36
Simvastatin Approved Phase 4,Phase 2,Phase 3 79902-63-9 54454
37
Clarithromycin Approved Phase 4,Phase 2,Phase 3,Not Applicable 81103-11-9 84029
38
Etoricoxib Approved, Investigational Phase 4 202409-33-4 123619
39
Montelukast Approved Phase 4 158966-92-8 5281040
40
Cetylpyridinium Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 7773-52-6
41
Silicon Approved, Investigational Phase 4,Phase 1,Phase 2 7440-21-3 4082203
42
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Not Applicable 50-02-2 5743
43
Mepivacaine Approved, Vet_approved Phase 4,Not Applicable 96-88-8 4062
44
Ibuprofen Approved Phase 4,Phase 2,Phase 3,Not Applicable 15687-27-1 3672
45
Aspirin Approved, Vet_approved Phase 4,Phase 2,Phase 3,Not Applicable 50-78-2 2244
46
Zoledronic acid Approved Phase 4 118072-93-8 68740
47
Coal tar Approved Phase 4,Phase 3,Not Applicable 8007-45-2
48
Hydrogen peroxide Approved, Vet_approved Phase 4,Not Applicable 7722-84-1 784
49
Penicillin V Approved, Vet_approved Phase 4 87-08-1 6869
50
Methyltestosterone Approved Phase 4 58-18-4 6010

Interventional clinical trials:

(show top 50) (show all 1219)
# Name Status NCT ID Phase Drugs
1 Clinical Investigation of the Effects of Colgate Total Toothpaste as Compared to a Matching Placebo on Periodontal Disease and Systemic Inflammatory Markers Unknown status NCT02670135 Phase 4 Triclosan Containing Toothpaste;Triclosan Free Toothpaste
2 The Treatment of Periodontal Diseases Unknown status NCT01318928 Phase 4 Metronidazol
3 Norplant and Irregular Bleeding/Spotting Unknown status NCT00064766 Phase 4 doxycycline
4 Effect of Actonel on Periodontal Health of Postmenopausal Women Unknown status NCT00594334 Phase 4 Risedronate
5 The Efficacy of Cyanoacrylate Adhesive (PeriAcryl®90 HV) in Periodontal Wound Healing Unknown status NCT02826109 Phase 4
6 Role of Stress Reduction Protocol on Outcome of Periodontal Therapy Unknown status NCT02487862 Phase 4
7 Periodontal Therapy in Coronary Artery Patients Unknown status NCT01609725 Phase 4
8 Efficacy and Safety of a Commercially Available Injectable Hyaluronic Acid Dental Filler for Periodontal Pockets Unknown status NCT02391974 Phase 4
9 Metronidazole and Amoxicillin for the Treatment of Type 2 Diabetic Subjects With Periodontitis Unknown status NCT02135952 Phase 4 MTZ+AMX
10 Clinical, Microbiological and Biochemical Effects of the Antimicrobial Photodynamic Therapy Unknown status NCT01532674 Phase 4
11 Clinical and Microbiological Effects of an Essential Oils Solution Used as an Adjunct to Daily Oral Hygiene Practices in Chronic Periodontitis Patients in Supportive Care Unknown status NCT01195493 Phase 4
12 Study of Scaling and Root Planing With PerioWave Versus Scaling and Root Planing Alone in Chronic Periodontitis Unknown status NCT00297531 Phase 4
13 SRP in Combination With PERIOWAVE in Comparison to SRP Alone in Chronic Periodontitis Unknown status NCT00296881 Phase 4
14 Methodology Antiseptic Application, Influence on Oral Biofilm. Unknown status NCT02267239 Phase 4 essential oils, immersion;Chlorhexidine, immersion;essential oils, mouthwash;chlorhexidine, mouthwash
15 Efficacy of Three Antibiotic Protocols for Aggressive Periodontitis Treatment Unknown status NCT02839421 Phase 4 Scaling and Root Planing combined with moxifloxacin
16 Evaluation of a Lateral Window Technique Augmentation for Maxillary Sinus Using Ultrasound Activated Pins Unknown status NCT02449707 Phase 4
17 Pinhole Surgical Technique With And Without Use Of Buttons For Treatment Of Multiple Gingival Recessions: RCT Unknown status NCT02632968 Phase 4
18 Laser De-epithelialization for Epithelial Exclusion in Root Coverage Procedure: a Clinical Study Unknown status NCT02626117 Phase 4
19 Platelet Rich Fibrin in the Treatment of Palatal Wounds Unknown status NCT02438046 Phase 4
20 Connective Tissue Graft Versus Mucograft Collagen Matrix for Coverage of Multiple Gingival Recession Defects Unknown status NCT01440426 Phase 4
21 Effect of Probiotic Lozenges on Halitosis in Patients With Chronic Periodontitis Unknown status NCT02789436 Phase 4 L. reuteri Prodentis® lozenges
22 Anticaries Effect of Probiotic Lactobacillus Brevis CD2 (Lb CD2). Unknown status NCT01778699 Phase 4
23 Adhesion of Connective Tissue Around Laser-treated Abutments for Dental Implants - Clinical Trial in Humans Unknown status NCT01954485 Phase 4
24 Relationship of Periodontal Disease Treatment and Type 2 Diabetes Mellitus in the Gullah Population Completed NCT01798225 Phase 4 Placebo;Doxycycline
25 Conventional or Minimally Invasive Surgical Technique for the Treatment of Furcation Defects Using Enamel Matrix Derivative and Anorganic Bovine Bone - a Randomized Controlled Clinical Trial. Completed NCT02102360 Phase 4
26 EMD and/or Bone Substitute for the Treatment of Class II Furcations Completed NCT02474498 Phase 4 EMD
27 Pediatric Study to Access Pharmacokinetics and Safety of Oraqix Gel Completed NCT01591616 Phase 4 lidocaine and prilocaine
28 Efficacy of Two Oral Hygiene Regimens in the Reduction of Dentin Hypersensitivity After Periodontal Treatment Completed NCT02461030 Phase 4 In-office and at home Colgate sensitive pro-relief - CSPR;In-office Villevie® prophy paste + Colgate Toothpaste
29 Locally Delivered Doxycycline Adjunct to Nonsurgical Periodontal Therapy. Completed NCT02487186 Phase 4 Doxicicline
30 Melatonin as an Adjunctive Therapy for Chronic Periodontitis. Completed NCT03368430 Phase 4 Placebo
31 Study on Regenerative Treatment of Intra-bony Defects Completed NCT00757159 Phase 4
32 Long-term Safety of Minocycline in Patients With Gum Disease Completed NCT00668746 Phase 4 Minocycline HCl microspheres
33 Interaction Between Chlorhexidine and Fluoride Completed NCT02935322 Phase 4 0.12 % chlorhexidine + 0.2 % NaF mouthrinse;0.2 % NaF mouthrinse;0.12% chlorhexidine
34 A Clinical Trial to Test the Effect of Experimental Mouth Rinse on Gum Disease Completed NCT02065414 Phase 4
35 A Clinical Trial to Study the Effect of Lycopene in Patients With Gum Disease and type2 Diabetes Mellitus Completed NCT02263352 Phase 4 Lycored soft gels Jagsonpal Pharma, Systemic 8mgms/day
36 Prospective Double-Blind Randomized Controlled Clinical Trial in the Gingivitis Prevention With OPCs Completed NCT02515929 Phase 4
37 Photodynamic Therapy During Supportive Periodontal Therapy Completed NCT02666573 Phase 4
38 Host Modulatory Effects of β-glucan on Localized Aggressive Periodontitis Completed NCT02402296 Phase 4 β-1,3/1,6-D-glucan
39 Effect of Arthrospira Platensis (Spirulina) as an Adjunct to Scaling and Root Planing on Salivary Antioxidant Levels in Chronic Periodontitis Subjects Completed NCT02886676 Phase 4 Spirulina capsules
40 Antimicrobial Therapy as Adjunct to Periodontal Treatment: Effect of Timing Completed NCT02197260 Phase 4 3/d 500 mg metronidazole plus 375 mg amoxicillin for 7 days
41 Evaluation of Photodynamic Treatment FOTOSAN® Efficacy in Periodontology Completed NCT02030470 Phase 4
42 Impact of Periodontal Treatment on Serum Levels of Hepcidin and Hemoglobin Completed NCT02641210 Phase 4 Albendazole
43 Effects of the Variation in the Time of Systemic Administration of Metronidazole and Amoxicillin Associated to the Non-surgical Therapy of Chronic Periodontitis. Completed NCT01211223 Phase 4 Administration of Metronidazole plus Amoxicillin
44 Effect of Scaling and Root Planing Along With Topical Application of Commercially Available Curcuma Longa Gel on Superoxide Dismutase and Malondialdehyde Levels in Saliva of Chronic Periodontitis Patients Completed NCT02442453 Phase 4 Topical application of curenext gel;Placebo
45 Mechanical-chemical Gingival Therapy in Diabetics and/or Obese Completed NCT02123563 Phase 4
46 Sodium Alendronate in Non Surgical Periodontal Therapy Completed NCT02470611 Phase 4 Sodium alendronate
47 DFDBA and Xenograft (Cerabone)TM With Decortication in Intrabony Defects Completed NCT02949557 Phase 4
48 Treatment of Periodontitis by Conventional 4 Weekly Sections or Within 24 Hours Completed NCT02215460 Phase 4 FMS chlorhexidine rinse;FMS placebo rinse;FMS azithromycin tablets;FMS placebo tablets;QS azithromycin tablets;QS placebo tablets;QS chlorhexidine rinse;QS placebo rinse
49 Bacteremia in Periodontal Patients Completed NCT02215473 Phase 4 Chlorhexidine gluconate mouth rinse
50 Local Minocycline to Reduce Future Inflammation and Bone Loss in Periodontal Maintenance Patients Completed NCT01647282 Phase 4 locally-applied minocycline HCl (1 mg)

Search NIH Clinical Center for Periodontal Disease

Inferred drug relations via UMLS 73 / NDF-RT 51 :


Cochrane evidence based reviews: periodontal diseases

Genetic Tests for Periodontal Disease

Anatomical Context for Periodontal Disease

MalaCards organs/tissues related to Periodontal Disease:

41
Bone, Testes, Kidney, Heart, Neutrophil, Endothelial, Liver

Publications for Periodontal Disease

Articles related to Periodontal Disease:

(show top 50) (show all 1100)
# Title Authors Year
1
Squamous Cell Carcinoma of the Gingiva Mimicking Periodontal Disease: A Diagnostic Challenge and Therapeutic Dilemma. ( 29447319 )
2018
2
The immunopathogenic and immunomodulatory effects of interleukin-12 in periodontal disease. ( 29411897 )
2018
3
Association between obstructive sleep apnea and comorbidities with periodontal disease in adults. ( 29962700 )
2018
4
Risk of colorectal cancer in patients with periodontal disease severity: a nationwide, population-based cohort study. ( 29397431 )
2018
5
Evaluating periodontal disease misclassification mechanisms under partial-mouth recording protocols. ( 29385644 )
2018
6
The effect of periodontal disease treatment in patients with continuous ambulatory peritoneal dialysis. ( 29926368 )
2018
7
Salivary and Serum Antioxidants in Women with Preeclampsia with or Without Periodontal Disease. ( 29391673 )
2018
8
Periodontal disease: What nurses need to know. ( 29923917 )
2018
9
Antimicrobial activity of amixicile against treponema denticola and other oral spirochetes associated with periodontal disease. ( 29958324 )
2018
10
Effect of a comprehensive plan for periodontal disease care on oral health-related quality of life in patients with periodontal disease in Taiwan. ( 29384859 )
2018
11
Clinical effect of a dentifrice containing three kinds of bactericidal ingredients on periodontal disease: a pilot study in patients undergoing supportive periodontal therapy. ( 29426362 )
2018
12
Factors affecting periodontal disease referral and the adherence to guidelines among general dentists. ( 29947419 )
2018
13
Efficacy of local phytotherapy in the nonsurgical treatment of periodontal disease: A systematic review. ( 29352465 )
2018
14
Periodontal disease and susceptibility to breast cancer: a meta-analysis of observational studies. ( 29974484 )
2018
15
Contribution of Diabetes to the Incidence and Prevalence of Comorbid Conditions (Cancer, Periodontal Disease, Fracture, Impaired Cognitive Function, and Depression): A Systematic Review of Epidemiological Studies in Japanese Populations. ( 29937469 )
2018
16
Gingival Periodontal Disease (PD) Level-Butyric Acid Affects the Systemic Blood and Brain Organ: Insights Into the Systemic Inflammation of Periodontal Disease. ( 29915575 )
2018
17
Knowledge, attitudes, and practice behaviors of medical specialists for the relationship between diabetes and periodontal disease: A questionnaire survey. ( 29915755 )
2018
18
Denture-Associated Oral Microbiome and Periodontal Disease Causing an Anaerobic Pyogenic Liver Abscess in an Immunocompetent Patient: A Case report and Review of the Literature. ( 29915637 )
2018
19
Periodontal disease prevalence: Right time to address the challenges. ( 29962696 )
2018
20
A cross-sectional study to estimate prevalence of periodontal disease in a population of dogs (Canis familiaris) in commercial breeding facilities in Indiana and Illinois. ( 29346448 )
2018
21
Correlation between interleukin-1I^ and matrix metalloproteinase-1 levels in crevicular fluid with a proposed periodontal disease index in children. ( 29962699 )
2018
22
People who report practicing interdental cleaning frequently are less likely to have caries and periodontal disease. ( 29958648 )
2018
23
Interferon Crevicular Fluid Profile and Correlation with Periodontal Disease and Wound Healing: A Systemic Review of Recent Data. ( 29966238 )
2018
24
Cowden Syndrome Associated with Severe Periodontal Disease: A Short Literature Review and a Case Report. ( 29946579 )
2018
25
Serotypes of <i>Aggregatibacter actinomycetemcomitans</i> in relation to periodontal status and assessment of leukotoxin in periodontal disease: A clinico-microbiological study. ( 29962698 )
2018
26
Dental treatment of a rare case of pyoderma gangrenosum with aggressive periodontal disease. ( 29945713 )
2018
27
From manual periodontal probing to digital 3-D imaging to endoscopic capillaroscopy: Recent advances in periodontal disease diagnosis. ( 29974960 )
2018
28
Inflammatory and Oxidative Responses in Pregnancies With Obesity and Periodontal Disease. ( 29343164 )
2018
29
Family History of MI, Smoking, and Risk of Periodontal Disease. ( 29928831 )
2018
30
Periodontal Disease Assessed Using Clinical Dental Measurements and Cancer Risk in the ARIC Study. ( 29342298 )
2018
31
Antirheumatic medication and salivary MMP-8, a biomarker for periodontal disease. ( 29969841 )
2018
32
Association between interleukin-8 levels and chronic periodontal disease: A PRISMA-compliant systematic review and meta-analysis. ( 28562542 )
2017
33
The relationship between periodontal disease, tooth loss and decreased skeletal bone mineral density in ageing women. ( 28812320 )
2017
34
Impact of Yoga on Periodontal Disease and Stress Management. ( 29422742 )
2017
35
Periodontal disease and FAM20A mutations. ( 28298625 )
2017
36
Association between pro-inflammatory cytokine interleukin-33 and periodontal disease in the elderly: A retrospective study. ( 29386793 )
2017
37
Periodontal disease in Chinese patients with systemic lupus erythematosus. ( 28631047 )
2017
38
Periodontal Disease and Incident Cancer Risk among Postmenopausal Women: Results from the Women's Health Initiative Observational Cohort. ( 28765338 )
2017
39
Knowledge, Attitude, and Awareness among Diabetic Patients in Davangere about the Association between Diabetes and Periodontal Disease. ( 29387625 )
2017
40
Correlation of ABO Blood Group Phenotype and Rhesus Factor with Periodontal Disease: An Observational Study. ( 28839412 )
2017
41
Treatment of experimental periodontal disease by laser therapy in simvastatin-modified rats. ( 28877277 )
2017
42
Thermoreversible in situ gel for subgingival delivery of simvastatin for treatment of periodontal disease. ( 28929053 )
2017
43
Combined antioxidant effects of Neem extract, bacteria, red blood cells and Lysozyme: possible relation to periodontal disease. ( 28797303 )
2017
44
Periodontal disease, tooth loss and colorectal cancer risk: Results from the Nurses' Health Study. ( 27778343 )
2017
45
Salivary Alkaline Phosphatase as a Noninvasive Marker for Periodontal Disease in Children with Uncontrolled Type 1 Diabetes Mellitus. ( 28052205 )
2017
46
Relationship Between Periodontal Disease and Serum Factors in Patients Undergoing Hemodialysis. ( 29399214 )
2017
47
Association between Periodontal disease and Prostate cancer: Results of a 12-year Longitudinal Cohort Study in South Korea. ( 28928887 )
2017
48
Immediate implant placement and complete mouth rehabilitation with CAD-CAM titanium frameworks and cemented crowns for a patient with severe periodontal disease: A clinical report. ( 28781070 )
2017
49
Periodontal disease and risk of non-Hodgkin lymphoma in the Health Professionals Follow-Up Study. ( 27861844 )
2017
50
Dental health awareness, attitude, and dental health-care seeking practices as risk indicators for the prevalence of periodontal disease among 15-17-year-old school children in Kozhikode district, Kerala, India. ( 29398860 )
2017

Variations for Periodontal Disease

Expression for Periodontal Disease

Search GEO for disease gene expression data for Periodontal Disease.

Pathways for Periodontal Disease